257 related articles for article (PubMed ID: 6037449)
1. Ovulation inhibition with sequential therapy. A continuing clinical study of fertility control.
Suran RR
Fertil Steril; 1967; 18(5):598-615. PubMed ID: 6037449
[TBL] [Abstract][Full Text] [Related]
2. Menstrual regulation by sequential hormone therapy.
Beaton JH
West J Surg Obstet Gynecol; 1964; 72():160-3. PubMed ID: 12332438
[TBL] [Abstract][Full Text] [Related]
3. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
Weikel JH; Nelson LW
J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
[TBL] [Abstract][Full Text] [Related]
4. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
6. Some observations on the changes in capillary resistance in oral contraceptive users.
Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
[TBL] [Abstract][Full Text] [Related]
7. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical function of patients using oral contraceptives.
Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
[TBL] [Abstract][Full Text] [Related]
9. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration.
Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S
Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955
[TBL] [Abstract][Full Text] [Related]
10. The effect of various contraceptive hormonal therapies in women with normal and diabetic oral glucose tolerance test.
Aznar R; Lara R; Zarco D; González L
Contraception; 1976 Mar; 13(3):299-311. PubMed ID: 55331
[TBL] [Abstract][Full Text] [Related]
11. Megestrol acetate concentrations in plasma and milk during administration of an oral contraceptive containing 4 mg megestrol acetate to nursing women.
Nilsson S; Nygren KG; Johansson ED
Contraception; 1977 Dec; 16(6):615-24. PubMed ID: 606501
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate metabolism of Indian women taking steroid contraceptives.
Barsivala VM; Virkar K; Kulkarni RD
Fertil Steril; 1976 Jan; 27(1):87-91. PubMed ID: 1245247
[TBL] [Abstract][Full Text] [Related]
13. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
[TBL] [Abstract][Full Text] [Related]
14. Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
Spona J; Feichtinger W; Kindermann C; Moore C; Mellinger U; Walter F; Gräser T
Contraception; 1997 Sep; 56(3):185-91. PubMed ID: 9347211
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of a new oral contraceptive, 'Pregnon'.
van de Walle J; Weijers MJ
Curr Med Res Opin; 1975; 3(3):151-6. PubMed ID: 1149483
[TBL] [Abstract][Full Text] [Related]
16. Invluence of oral contraceptives on circulating immune response. II. Effect of progestogenic and estrogenic components.
Rangnekar KN; Rao SS; Joshi UM
Contraception; 1974 Nov; 10(5):527-33. PubMed ID: 4141295
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
[TBL] [Abstract][Full Text] [Related]
18. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 2. Maintenance of ovarian function in patients with megestrol acetate implants.
Benagiano G; Ermini M; Carenza L; Donini P
Acta Endocrinol (Copenh); 1973 Jun; 73(2):347-59. PubMed ID: 4740834
[TBL] [Abstract][Full Text] [Related]
19. Multiple arterial occlusions and hypertension probably caused by an oral contraceptive: a patient in whom the development of renovascular hypertension has been followed.
Delin K; Aurell M; Claes G; Teger-Nilsson AC; Wallentin I
Clin Nephrol; 1976 Oct; 6(4):453-7. PubMed ID: 788979
[TBL] [Abstract][Full Text] [Related]
20. Use of Anovlar in gynaecological disorders and contraception.
Shahani SM; Chiklikar A
J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
